Neurology AdvisorDoes Brain Reserve Attenuate the Effects of Alzheimer Disease Pathology?

⚠️ Small Study / Early Comparative Evidence

Brain reserve — indexed here by brain-predicted age difference (brain-PAD) — and socioeconomic status (SES) were associated with reduced cognitive impact of AD pathology in cognitively unimpaired adults aged 65–80. Findings are hypothesis-generating and limited by cross-sectional design and a predominantly White, well-educated sample.

Clinical Considerations

• Brain-PAD interacted with p-tau217 levels for working memory, episodic memory, processing speed, and executive function across moderation analyses
• Years of education correlated with cognitive performance across domains but did not moderate the p-tau217–cognition relationship
• Objective SES showed evidence of moderating AD pathology’s cognitive impact, though effect sizes were modest (β range, 0.11–0.21)
• Volumetric AD signature did not moderate the p-tau217 or PET centiloid–cognition relationships

Practice Applications

• Recognize brain reserve as a potential buffer in cognitively unimpaired patients with early AD biomarker burden
• Integrate SES context when interpreting cognitive resilience in patients with elevated p-tau217
• Avoid overstating protective effects; this cohort was cognitively unimpaired, well-educated, and predominantly non-Hispanic White
• Monitor longitudinal data as IGNITE trial follow-up matures; cross-sectional findings do not establish causal pathways